Aortech International logo

AOR - Aortech International Share Price

103.5p 2.5  2.5%

Last Trade - 4:31pm

Sector
Healthcare
Size
Micro Cap
Market Cap £14.8m
Enterprise Value £12.5m
Revenue £526k
Position in Universe 1432nd / 1844
Bullish
Bearish
Unlock AOR Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AOR Revenue Unlock AOR Revenue

Net Income

AOR Net Income Unlock AOR Revenue

Normalised EPS

AOR Normalised EPS Unlock AOR Revenue

PE Ratio Range

AOR PE Ratio Range Unlock AOR Revenue

Dividend Yield Range

AOR Dividend Yield Range Unlock AOR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AOR EPS Forecasts Unlock AOR Revenue
Profile Summary

AorTech International plc is a biomaterials and medical device intellectual property (IP) company. The Company is focused on the commercialization of its biomedical polymer technology, components and medical devices. The Company has developed biostable, implantable polymers, including Elast-Eon and ECSil, which are long-term implantable co-polymers. Its Elast-Eon technology is available in a range of mechanical properties (Elastomers to rigid polymers), 70 Shore A to 80 Shore D. Its ECSil technology is available in a range of mechanical properties, but extends the softer materials to 70 Shore A. The Company has developed Elast-Eon and Reaction Injection Molding (RIM) technology for use in high-precision medical device components. Its polymers are developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. These polymers can be processed using conventional thermoplastic extrusion and molding techniques.

Directors
Last Annual March 31st, 2019
Last Interim September 30th, 2019
Incorporated November 21, 1996
Public Since February 12, 1997
No. of Shareholders: n/a
No. of Employees: 3
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 19,519,386
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AOR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AOR
Upcoming Events for AOR
Similar to AOR
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.